Eli Lilly’s Weight-Loss Pill Foundayo Secures First European Approval in Britain
Eli Lilly has secured a major win in the fast-growing market for oral weight-loss drugs after Britain became the first…
Aleniglipron GLP-1 Pill Shows 12.1% Weight Loss in 36 Weeks
A new once-daily oral GLP-1 drug is adding momentum to the rapidly changing obesity-treatment market. In a Phase 2b trial…
McAllen, Texas: The Most Obese City in the World?
McAllen, Texas, in the Rio Grande Valley, has become a striking example of how obesity can be influenced by much…
GLP-1 Drug Names: List of GLP-1 Receptor Agonists and Brand Names 2026
GLP-1 drugs have become a major part of modern treatment for type 2 diabetes and obesity. These medicines mimic the…
BMI vs. BRI: The Body Measurement Showdown (And Which One You Should Trust)
For decades, the Body Mass Index (BMI) has been the gold standard for assessing whether a person is at a healthy weight.…
List of GLP-1 Drugs: 2026 Update
GLP-1 drugs have become some of the most closely watched medicines in diabetes and obesity treatment. These medicines mimic the…
How Much Does the New Oral GLP-1 Drug Cost in 2026?
The obesity-drug market has entered a new phase in 2026: GLP-1 weight-loss medicines are moving from weekly injections to daily…